196 related articles for article (PubMed ID: 37280363)
1. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming.
Zhang ZJ; Wu QF; Ren AQ; Chen Q; Shi JZ; Li JP; Liu XY; Zhang ZJ; Tang YZ; Zhao Y; Yao NN; Zhang XY; Liu CP; Dong G; Zhao JX; Xu MJ; Yue YQ; Hu J; Sun F; Liu Y; Ao QL; Zhou FL; Wu H; Zhang TC; Zhu HC
Acta Pharmacol Sin; 2023 Nov; 44(11):2282-2295. PubMed ID: 37280363
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival.
Pathria G; Scott DA; Feng Y; Sang Lee J; Fujita Y; Zhang G; Sahu AD; Ruppin E; Herlyn M; Osterman AL; Ronai ZA
EMBO J; 2018 Oct; 37(20):. PubMed ID: 30209241
[TBL] [Abstract][Full Text] [Related]
3. TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.
O'Leary EM; Tian Y; Nigdelioglu R; Witt LJ; Cetin-Atalay R; Meliton AY; Woods PS; Kimmig LM; Sun KA; Gökalp GA; Mutlu GM; Hamanaka RB
Am J Respir Cell Mol Biol; 2020 Nov; 63(5):601-612. PubMed ID: 32668192
[TBL] [Abstract][Full Text] [Related]
4. Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer.
Zhou X; Zhou R; Rao X; Hong J; Li Q; Jie X; Wang J; Xu Y; Zhu K; Li Z; Wu G
Cell Death Dis; 2022 Jul; 13(7):636. PubMed ID: 35864117
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
6. L-2hydroxyglutaric acid rewires amino acid metabolism in colorectal cancer via the mTOR-ATF4 axis.
Tabata S; Kojima Y; Sakamoto T; Igarashi K; Umetsu K; Ishikawa T; Hirayama A; Kajino-Sakamoto R; Sakamoto N; Yasumoto KI; Okano K; Suzuki Y; Yachida S; Aoki M; Soga T
Oncogene; 2023 Apr; 42(16):1294-1307. PubMed ID: 36879117
[TBL] [Abstract][Full Text] [Related]
7. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.
Ye J; Kumanova M; Hart LS; Sloane K; Zhang H; De Panis DN; Bobrovnikova-Marjon E; Diehl JA; Ron D; Koumenis C
EMBO J; 2010 Jun; 29(12):2082-96. PubMed ID: 20473272
[TBL] [Abstract][Full Text] [Related]
8. GCN2- and eIF2α-phosphorylation-independent, but ATF4-dependent, induction of CARE-containing genes in methionine-deficient cells.
Mazor KM; Stipanuk MH
Amino Acids; 2016 Dec; 48(12):2831-2842. PubMed ID: 27613409
[TBL] [Abstract][Full Text] [Related]
9. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation.
Ren P; Yue M; Xiao D; Xiu R; Gan L; Liu H; Qing G
J Pathol; 2015 Jan; 235(1):90-100. PubMed ID: 25142020
[TBL] [Abstract][Full Text] [Related]
10. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
11. GZD824 Inhibits GCN2 and Sensitizes Cancer Cells to Amino Acid Starvation Stress.
Kato Y; Kunimasa K; Takahashi M; Harada A; Nagasawa I; Osawa M; Sugimoto Y; Tomida A
Mol Pharmacol; 2020 Dec; 98(6):669-676. PubMed ID: 33033108
[TBL] [Abstract][Full Text] [Related]
12. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).
Wasag B; Lierman E; Meeus P; Cools J; Vandenberghe P
Haematologica; 2011 Jun; 96(6):922-6. PubMed ID: 21330321
[TBL] [Abstract][Full Text] [Related]
13. Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis.
Wang M; Li J; Yang X; Yan Q; Wang H; Xu X; Lu Y; Li D; Wang Y; Sun R; Zhang S; Zhang Y; Zhang Z; Meng F; Li Y
Cancer Gene Ther; 2023 Nov; 30(11):1485-1497. PubMed ID: 37542132
[TBL] [Abstract][Full Text] [Related]
14. Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.
Cowell JK; Qin H; Hu T; Wu Q; Bhole A; Ren M
Int J Cancer; 2017 Nov; 141(9):1822-1829. PubMed ID: 28646488
[TBL] [Abstract][Full Text] [Related]
15. The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.
Ryan MR; Sohl CD; Luo B; Anderson KS
Mol Cancer Res; 2019 Feb; 17(2):532-543. PubMed ID: 30257990
[TBL] [Abstract][Full Text] [Related]
16. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
[TBL] [Abstract][Full Text] [Related]
17. Decreased ATF4 expression as a mechanism of acquired resistance to long-term amino acid limitation in cancer cells.
Mesclon F; Lambert-Langlais S; Carraro V; Parry L; Hainault I; Jousse C; Maurin AC; Bruhat A; Fafournoux P; Averous J
Oncotarget; 2017 Apr; 8(16):27440-27453. PubMed ID: 28460466
[TBL] [Abstract][Full Text] [Related]
18. A cell-based chemical-genetic screen for amino acid stress response inhibitors reveals torins reverse stress kinase GCN2 signaling.
Brüggenthies JB; Fiore A; Russier M; Bitsina C; Brötzmann J; Kordes S; Menninger S; Wolf A; Conti E; Eickhoff JE; Murray PJ
J Biol Chem; 2022 Dec; 298(12):102629. PubMed ID: 36273589
[TBL] [Abstract][Full Text] [Related]
19. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
[TBL] [Abstract][Full Text] [Related]
20. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
Ren M; Qin H; Ren R; Tidwell J; Cowell JK
Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
